The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Mechanisms of LDL oxidation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Myeloperoxidase: friend and foe
Klebanoff, S. J. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204697 · Cited by 2,282
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90224-7 · Cited by 2,194
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
Continuous Monitoring of in Vztro Oxidation of Human Low Density Lipoprotein
Esterbauer, H., Striegl, G., Puhl, H., & Rotheneder, M. (1989) · Free Radical Research Communications · doi:10.3109/10715768909073429 · Cited by 1,790
Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
Low Density Lipoprotein Oxidation and Its Pathobiological Significance
Steinberg, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20963 · Cited by 1,642
Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., & Steinberg, D. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3883 · Cited by 1,626
Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., & van der Vliet, A. (1998) · Nature · doi:10.1038/34923 · Cited by 1,496
The role of oxidized lipoproteins in atherogenesis
Berliner, J. A., & Heinecke, J. W. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02173-6 · Cited by 1,366
Daugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
Lipid hydroperoxide generation, turnover, and effector action in biological systems
Girotti, A. W. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32182-9 · Cited by 1,200
Nakamura, H., Arakawa, K., Itakura, H., Kitabatake, A., Goto, Y., Toyota, T., Nakaya, N., Nishimoto, S., Muranaka, M., Yamamoto, A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69472-5 · Cited by 941
Hazen, S. L., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119379 · Cited by 842
Lipids and Lipoproteins in Patients With Type 2 Diabetes
Krauss, R. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1496 · Cited by 756
Lewis A. Conner Memorial Lecture: Oxidative Modification of LDL and Atherogenesis
Steinberg, D. (1997) · Circulation · doi:10.1161/01.cir.95.4.1062 · Cited by 748
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
Wang, Z., Nicholls, S. J., Rodriguez, E. R., Kummu, O., Hörkkö, S., Barnard, J., Reynolds, W. F., Topol, E. J., DiDonato, J. A., & Hazen, S. L. (2007) · Nature Medicine · doi:10.1038/nm1637 · Cited by 705
Myeloperoxidase, a Leukocyte-Derived Vascular NO Oxidase
Eiserich, J. P., Baldus, S., Brennan, M.-L., Ma, W., Zhang, C., Tousson, A., Castro, L., Lusis, A. J., Nauseef, W. M., White, C. R., et al. (2002) · Science · doi:10.1126/science.1106830 · Cited by 685
Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime
Steinberg, D. (2002) · Nature Medicine · doi:10.1038/nm1102-1211 · Cited by 679
Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell, L. J., Arnold, L., Flowers, D., Waeg, G., Malle, E., & Stocker, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118576 · Cited by 592
Lipid advanced glycosylation: pathway for lipid oxidation in vivo.
Bucala, R., Makita, Z., Koschinsky, T., Cerami, A., & Vlassara, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6434 · Cited by 571
Mammalian lipoxygenases: molecular structures and functions
Yamamoto, S. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90297-9 · Cited by 571
Heinecke, J. W., Rosen, H., & Chait, A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111609 · Cited by 536
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523
The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
Witztum, J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00111-6 · Cited by 440
Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Glass, C. K., Sigal, E., Witztum, J. L., & Steinberg, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6959 · Cited by 426
A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
Parthasarathy, S., Wieland, E., & Steinberg, D. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.1046 · Cited by 415
Merched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N., & Chan, L. (2008) · The FASEB Journal · doi:10.1096/fj.08-112201 · Cited by 414 · cited 1×
“In addition, the global knockout of 12/15lipoxygenase increased rather than decreased atherosclerosis in apolipoprotein E-knockout mice [82].”
BackgroundInhibition of low‐density lipoprotein oxidation by nitric oxide Potential role in atherogenesis
Hogg, N., Kalyanaraman, B., Joseph, J., Struck, A., & Parthasarathy, S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81706-6 · Cited by 400
Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Sigal, E., Särkioja, T., Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115111 · Cited by 379
The LDL modification hypothesis of atherogenesis: an update
Steinberg, D. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800087-jlr200 · Cited by 375
Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum.
Day, J. F., Thorpe, S. R., & Baynes, J. W. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37845-6 · Cited by 334
Biological interactions of α,β-unsaturated aldehydes
Witz, G. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90137-8 · Cited by 334
Increased atherosclerosis in myeloperoxidase-deficient mice
Brennan, M.-L., Anderson, M. M., Shih, D. M., Qu, X.-D., Wang, X., Mehta, A. C., Lim, L. L., Shi, W., Hazen, S. L., Jacob, J. S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci8797 · Cited by 323
The principal site of nonenzymatic glycosylation of human serum albumin in vivo.
Garlick, R. L., & Mazer, J. S. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32384-6 · Cited by 316
Stadler, N., Lindner, R. A., & Davies, M. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000124892.90999.cb · Cited by 310
Indices of lipid peroxidation in vivo: strengths and limitations
Meagher, E. A., & FitzGerald, G. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00232-x · Cited by 299
Sparrow, C. P., Parthasarathy, S., & Steinberg, D. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38493-5 · Cited by 299
Lee, H., Shi, W., Tontonoz, P., Wang, S., Subbanagounder, G., Hedrick, C. C., Hama, S., Borromeo, C., Evans, R. M., Berliner, J. A., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.6.516 · Cited by 292
Milman, U., Blum, S., Shapira, C., Aronson, D., Miller-Lotan, R., Anbinder, Y., Alshiek, J., Bennett, L., Kostenko, M., Landau, M., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.153965 · Cited by 281
Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis
Heinecke, J. W. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00005 · Cited by 273
Steinbrecher, U. P., & Witztum, J. L. (1984) · Diabetes · doi:10.2337/diab.33.2.130 · Cited by 272
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
Ehrenwald, E., Chisolm, G. M., & Fox, P. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117127 · Cited by 261
Kawamura, M., Heinecke, J. W., & Chait, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117396 · Cited by 255
O'Donnell, V. B., Chumley, P. H., Hogg, N., Bloodsworth, A., Darley-Usmar, V. M., & Freeman, B. A. (1997) · Biochemistry · doi:10.1021/bi971891z · Cited by 253
Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques.
Folcik, V. A., Nivar-Aristy, R. A., Krajewski, L. P., & Cathcart, M. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118062 · Cited by 252
Harats, D., Shaish, A., George, J., Mulkins, M., Kurihara, H., Levkovitz, H., & Sigal, E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2100 · Cited by 238
Macrophage Apoptosis Exerts Divergent Effects on Atherogenesis as a Function of Lesion Stage
Gautier, E. L., Huby, T., Witztum, J. L., Ouzilleau, B., Miller, E. R., Saint-Charles, F., Aucouturier, P., Chapman, M. J., & Lesnik, P. (2009) · Circulation · doi:10.1161/circulationaha.108.806158 · Cited by 235
Myeloperoxidase: A Useful Biomarker for Cardiovascular Disease Risk Stratification?
Schindhelm, R. K., van der Zwan, L. P., Teerlink, T., & Scheffer, P. G. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.126029 · Cited by 234
Parthasarathy, S. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90139-1 · Cited by 233
Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development.
Shen, J., Herderick, E., Cornhill, J. F., Zsigmond, E., Kim, H. S., Kühn, H., Guevara, N. V., & Chan, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119029 · Cited by 233
Cyrus, T., Praticò, D., Zhao, L., Witztum, J. L., Rader, D. J., Rokach, J., FitzGerald, G. A., & Funk, C. D. (2001) · Circulation · doi:10.1161/01.cir.103.18.2277 · Cited by 232
Xanthine Oxidase Inhibition Reverses Endothelial Dysfunction in Heavy Smokers
Guthikonda, S., Sinkey, C., Barenz, T., & Haynes, W. G. (2003) · Circulation · doi:10.1161/01.cir.0000046448.26751.58 · Cited by 225
Infection and Inflammation Induce LDL Oxidation In Vivo
Memon, R. A., Staprans, I., Noor, M., Holleran, W. M., Uchida, Y., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1536 · Cited by 207
Gniwotta, C., Morrow, J. D., Roberts, L. J., & Kühn, H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.3236 · Cited by 196
Huo, Y., Zhao, L., Hyman, M. C., Shashkin, P., Harry, B. L., Burcin, T., Forlow, S. B., Stark, M. A., Smith, D. F., Clarke, S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143628.37680.f6 · Cited by 196
12/15-Lipoxygenase Gene Disruption Attenuates Atherogenesis in LDL Receptor–Deficient Mice
George, J., Afek, A., Shaish, A., Levkovitz, H., Bloom, N., Cyrus, T., Zhao, L., Funk, C. D., Sigal, E., & Harats, D. (2001) · Circulation · doi:10.1161/hc3901.095772 · Cited by 194
Yoshida, H., Quehenberger, O., Kondratenko, N., Green, S., & Steinberg, D. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.5.794 · Cited by 194
Self-citationNew insights on oxidative stress in the artery wall
STOCKER, R., & KEANEY, J. F. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01370.x · Cited by 188
Evidence for a Role of Phospholipid Oxidation Products in Atherogenesis
Berliner, J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00098-6 · Cited by 182
The Oxidation of Lipoproteins by Monocytes-Macrophages
Chisolm, G. M., Hazen, S. L., Fox, P. L., & Cathcart, M. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.25959 · Cited by 174
Jessup, W., Mohr, D., Gieseg, S. P., Dean, R. T., & Stocker, R. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(92)90029-m · Cited by 172
In vivo action of 15-lipoxygenase in early stages of human atherogenesis.
Kühn, H., Heydeck, D., Hugou, I., & Gniwotta, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119253 · Cited by 168
Bowie, A., Owens, D., Collins, P., Johnson, A., & Tomkin, G. H. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90084-8 · Cited by 166
Glucose transport in brain and retina: implications in the management and complications of diabetes
Kumagai, A. K. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199907/08)15:4<283::aid-dmrr42>3.0.co;2-u · Cited by 160
Oxygenation of lipoproteins by mammalian lipoxygenases
BELKNER, J., WIESNER, R., RATHMAN, J., BARNETT, J., SIGAL, E., & KÜHN, H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17755.x · Cited by 160
Levy, A. P., Levy, J. E., Kalet-Litman, S., Miller‐Lotan, R., Levy, N. S., Asaf, R., Guetta, J., Yang, C., Purushothaman, K., Fuster, V., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251020.24399.a2 · Cited by 159
Sparrow, C., & Olszewski, J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37709-9 · Cited by 158
Measuring Circulating Oxidized Low-Density Lipoprotein to Evaluate Coronary Risk
Tsimikas, S., & Witztum, J. L. (2001) · Circulation · doi:10.1161/01.cir.103.15.1930 · Cited by 155
Schöneich, C., Dillinger, U., von Bruchhausen, F., & Asmus, K. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90016-p · Cited by 154
Fraley, A. E., & Tsimikas, S. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000245255.40634.b5 · Cited by 153
Oxidative Modification of LDL: Its Pathological Role in Atherosclerosis
Itabe, H. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8095-9 · Cited by 145
Camejo, G., Halberg, C., Manschik-Lundin, A., Hurt‐Camejo, E., Rosengren, B. E., Olsson, H., Hansson, G. I., Forsberg, G., & Ylhen, B. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32564-5 · Cited by 142
Heinecke, J. W. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1113 · Cited by 140
Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein
Yoshida, H., Ishikawa, T., Hosoai, H., Suzukawa, M., Ayaori, M., Hisada, T., Sawada, S., Yonemura, A., Higashi, K., Ito, T., et al. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00256-7 · Cited by 129
Self-citationDoes an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?
Leake, D. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06035-2 · Cited by 116
Salomon, R., Underwood, R., DOYLE, M. V., Wang, A., & Libby, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2814 · Cited by 114
Gaut, J. P., & Heinecke, J. W. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00101-3 · Cited by 112
Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects
Tames, F. J., Mackness, M., Arrol, S., Laing, I., & Durrington, P. N. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90260-n · Cited by 107
Benz, D., Mol, M. J. T. M., Ezaki, M., Mori-Ito, N., Zelán, I., Miyanohara, A., Friedmann, T., Parthasarathy, S., Steinberg, D. H., & Witztum, J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5191 · Cited by 107
Younis, N. N., Charlton-Menys, V., Sharma, R., Soran, H., & Durrington, P. N. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.036 · Cited by 104
Hemochromatosis, Multiorgan Hemosiderosis, and Coronary Artery Disease
Miller, M. J. (1994) · JAMA · doi:10.1001/jama.1994.03520030073031 · Cited by 103
Myeloperoxidase binds to low‐density lipoprotein: potential implications for atherosclerosis
Carr, A. C., Myzak, M. C., Stocker, R., McCall, M. R., & Frei, B. B. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02227-4 · Cited by 102
Glycation as an atherogenic modification of LDL
Younis, N. N., Sharma, R., Soran, H., Charlton-Menys, V., Elseweidy, M. M., & Durrington, P. N. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328306a057 · Cited by 102
Acidic pH enables caeruloplasmin to catalyse the modification of low‐density lipoprotein
Lamb, D. J., & Leake, D. S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80348-x · Cited by 95
Diffusion of Nitric Oxide into Low Density Lipoprotein
Denicola, A., Batthyány, C., Lissi, E. A., Freeman, B. Α., Rubbo, H., & Radí, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106589200 · Cited by 94
Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin
Kisugi, R., Kouzuma, T., Yamamoto, T., Akizuki, S., Miyamoto, H., 染谷, 泰., Yokoyama, J., Abe, I., Hirai, N., & Ohnishi, A. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.001 · Cited by 93
Self-citationInhibition of macrophage-dependent low density lipoprotein oxidation by nitric-oxide donors.
Hogg, N., Struck, A. T., Goss, S. P. A., Santanam, N., Joseph, J., Parthasarathy, S., & Kalyanaraman, B. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41494-4 · Cited by 93
Boullier, A., Li, Y., Quehenberger, O., Palinski, W., Tabas, I. A., Witztum, J. L., & Miller, Y. I. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000210279.97308.9a · Cited by 87
Low density lipoprotein oxidation by stimulated neutrophils and ferritin
Abdalla, D. S. P., Čampa, A., & Monteiro, H. P. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90128-4 · Cited by 82
Lipid peroxidation and decomposition — Conflicting roles in plaque vulnerability and stability
Parthasarathy, S., Litvinov, D. Y., Selvarajan, K., & Garelnabi, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.03.002 · Cited by 79
Nitric oxide donor GEA 3162 inhibits endothelial cell‐mediated oxidation of low density lipoprotein
Malo‐Ranta, U., Ylä‐Herttuala, S., Metsä‐Ketelä, T., Jaakkola, O., Moilanen, E., Vuorinen, P., & Nikkari, T. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80269-6 · Cited by 79
Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo.
Lenten, B. J. V., Prieve, J., Navab, M., Hama, S. Y., Lusis, A. J., & Fogelman, A. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117898 · Cited by 74
Chait, A., & Heinecke, J. W. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199410000-00008 · Cited by 73
In Vivo Markers of Oxidative Stress and Therapeutic Interventions
Tsimikas, S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.006 · Cited by 67
Imanaga, Y., Sakata, N., Takebayashi, S., Matsunaga, A., Sasaki, J., Arakawa, K., Nagai, R., Horiuchi, S., Itabe, H., & Takano, T. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00396-2 · Cited by 65
Zhu, H., Takahashi, Y., Xu, W., Kawajiri, H., Murakami, T., Yamamoto, M., Iseki, S., Iwasaki, T., Hattori, H., & Yoshimoto, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212104200 · Cited by 65
Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein
Lamb, D. J., & Leake, D. S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00903-1 · Cited by 64
Are Body Iron Stores Related to the Risk of Coronary Heart Disease?
Ascherio, A., & Willett, W. C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404213301611 · Cited by 60
Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies
Li, D., Devaraj, S., Fuller, C., Bucala, R., & Jialal, I. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37563-5 · Cited by 50
Yoshida, H., Ishikawa, T., & Nakamura, H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.7.1438 · Cited by 47
Self-citationTapper, H., & Sundler, R. (1992) · Biochemical Journal · doi:10.1042/bj2810245 · Cited by 46
The role of lipoxygenase-isoforms in atherogenesis
Kühn, H., Römisch, I., & Belkner, J. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500131 · Cited by 46
Homocysteine strongly enhances metal-catalyzed LDL oxidation in the presence of cystine and cysteine
Pfanzagl, B., Tribl, F., Koller, E., & Moeslinger, T. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00057-1 · Cited by 44
Oxidation of low density lipoprotein by iron or copper at acidic pH.
Morgan, J., & Leake, D. S. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41087-9 · Cited by 43
Parthasarathy, S., & Steinberg, D. H. (1992) · Current Opinion in Lipidology · doi:10.1097/00041433-199210000-00002 · Cited by 38
Xu, W., Takahashi, Y., Sakashita, T., Iwasaki, T., Hattori, H., & Yoshimoto, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105093200 · Cited by 35
Yoshida, H., Ishikawa, T., Ayaori, M., Shige, H., Ito, T., Suzukawa, M., & Nakamura, H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00062-8 · Cited by 34
Self-citationKoba, S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00245-4 · Cited by 33
Noguchi, N. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01114-0 · Cited by 33
Kalet-Litman, S., Moreno, P., & Levy, A. P. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.002 · Cited by 33
Levy, A. P. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.002 · Cited by 30
Karten, B., Boechzelt, H., Abuja, P. M., Mittelbach, M., & Sattler, W. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33486-6 · Cited by 28
Hajjar, D. P., Farber, I. C., & Smith, S. C. L. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90201-9 · Cited by 27
Yoshida, H., Sasaki, K., Hirowatari, Y., Kurosawa, H., Sato, N., Furutani, N., & Tada, N. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.03.018 · Cited by 26
Self-citationTakahashi, Y., Zhu, H., Xu, W., Murakami, T., Iwasaki, T., Hattori, H., & Yoshimoto, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.182 · Cited by 26
Oxidation of LDL by rabbit and human 15-lipoxygenase: prevalence of nonenzymatic reactions
Heydeck, D., Upston, J. M., Viita, H., Ylä‐Herttuala, S., & Stocker, R. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31597-2 · Cited by 22
Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD
Roob, J. M., Rabold, T., Hayn, M., Khoschsorur, G., Resch, U., Holzer, H., & Winklhofer‐Roob, B. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780128.x · Cited by 18
Mechanism of low-density lipoprotein oxidation
Halliwell, B. B. (1993) · Current Opinion in Lipidology · doi:10.1097/00041433-199310000-00006 · Cited by 12
Sanguinetti, S. M., Schreier, L. E., Elbert, A. E., et al. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00276-7 · Cited by 8
Cited by
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Self-citationYuan, T., Yang, T., Chen, H., Fu, D., Hu, Y., Wang, J., Yuan, Q., Yu, H., Xu, W., & Xie, X. (2019) · Redox Biology · doi:10.1016/j.redox.2018.09.025 · Cited by 743
NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
Hoseini, Z., Sepahvand, F., Rashidi, B., Sahebkar, A., Masoudifar, A., & Mirzaei, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25930 · Cited by 458
Inflammation in atherosclerosis: pathophysiology and mechanisms
Ajoolabady, A., Pratico, D., Lin, L., Mantzoros, C. S., Bahijri, S., Tuomilehto, J., & Ren, J. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-07166-8 · Cited by 447
Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases
Trpkovic, A., Resanovic, I., Stanimirovic, J., Radak, D., Mousa, S. A., Cenic-Milosevic, D., Jevremovic, D., & Isenovic, E. R. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.992063 · Cited by 321
Metadata
- Authors
- Yoshida, H., & Kisugi, R.
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 411
- Issue
- 23-24
- Pages
- 1875-1882
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W2006956325
- Cited by
- 288
- References
- 128
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.